Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Privia Health Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Privia Health Group, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759655-26-000064
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Provider expense | 500,484 | 405,992 | 975,601 | 780,801 |
| Cost of platform | 69,357 | 64,918 | 137,777 | 124,444 |
| Sales and marketing | 8,002 | 6,805 | 16,136 | 13,727 |
| General and administrative | 39,658 | 37,519 | 81,131 | 69,240 |
| Depreciation and amortization | 3,356 | 2,583 | 6,637 | 4,484 |
| Total operating expenses | 620,857 | 517,817 | 1,217,282 | 992,696 |
| Operating income | 11,773 | 3,336 | 19,195 | 8,554 |
| Other income | 3,310 | — | 3,310 | — |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is Privia Health Group, Inc.'s G&A?
- Privia Health Group, Inc. (PRVA) reported G&A of $39.66M in Q2 2026.
- How has Privia Health Group, Inc.'s G&A changed year-over-year?
- Privia Health Group, Inc.'s G&A increased by 5.7% year-over-year, from $37.52M to $39.66M.
- What is the long-term trend for Privia Health Group, Inc.'s G&A?
- Over 4 years (2021 to 2025), Privia Health Group, Inc.'s G&A has grown at a -14.3% compound annual growth rate (CAGR), from $255.88M to $138.15M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Privia Health Group, Inc.'s g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude